BioArctic AB (publ)
SSE:BIOA-B.ST
227.8 (SEK) • At close February 20, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) SEK.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 615.995 | 228.291 | 23.146 | 62.347 | 281.773 | 713.97 | 140.706 | 105.613 | 41.573 |
| Cost of Revenue
| 269.678 | 74.326 | 55.067 | 50.242 | 72.422 | 145.357 | 0.266 | 0.238 | 0 |
| Gross Profit
| 346.317 | 153.965 | -31.921 | 12.105 | 209.351 | 568.613 | 140.44 | 105.375 | 41.573 |
| Gross Profit Ratio
| 0.562 | 0.674 | -1.379 | 0.194 | 0.743 | 0.796 | 0.998 | 0.998 | 1 |
| Reseach & Development Expenses
| 89.627 | 74.326 | 55.067 | 50.242 | 72.422 | 145.357 | 101.583 | 53.665 | 38.238 |
| General & Administrative Expenses
| 0 | 0 | 24.852 | 23.37 | 31.169 | 31.949 | 31.522 | 14.544 | 4.558 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 1.397 | 1.37 | 1.453 |
| SG&A
| 251.251 | 148.665 | 24.852 | 23.37 | 31.169 | 31.949 | 32.919 | 15.914 | 6.011 |
| Other Expenses
| 269.409 | 161.903 | 83.08 | 71.053 | 67.092 | 0.007 | 0.678 | 2.082 | 0.524 |
| Operating Expenses
| 89.627 | 161.903 | 107.932 | 94.423 | 98.261 | 82.786 | 117.095 | 44.774 | 37.273 |
| Operating Income
| 256.69 | -10.159 | -139.723 | -82.318 | 112.538 | 488.794 | 19.294 | 74.631 | 4.844 |
| Operating Income Ratio
| 0.417 | -0.045 | -6.037 | -1.32 | 0.399 | 0.685 | 0.137 | 0.707 | 0.117 |
| Total Other Income Expenses Net
| 19.796 | -1.008 | -0.789 | -4.373 | 0.438 | 3.766 | -3.655 | 13.535 | 0.491 |
| Income Before Tax
| 276.486 | -11.167 | -140.512 | -86.691 | 112.976 | 489.593 | 19.69 | 74.136 | 4.791 |
| Income Before Tax Ratio
| 0.449 | -0.049 | -6.071 | -1.39 | 0.401 | 0.686 | 0.14 | 0.702 | 0.115 |
| Income Tax Expense
| 47.237 | 0.011 | -20.723 | -18.174 | 24.507 | 107.991 | 4.534 | 16.556 | 1.081 |
| Net Income
| 229.249 | -11.178 | -119.789 | -68.517 | 88.468 | 381.602 | 15.157 | 57.58 | 3.71 |
| Net Income Ratio
| 0.372 | -0.049 | -5.175 | -1.099 | 0.314 | 0.534 | 0.108 | 0.545 | 0.089 |
| EPS
| 2.6 | -0.13 | -1.36 | -0.78 | 1 | 4.33 | 0.22 | 0.65 | 0.042 |
| EPS Diluted
| 2.59 | -0.13 | -1.36 | -0.78 | 1 | 4.33 | 0.22 | 0.65 | 0.042 |
| EBITDA
| 275.118 | 4.025 | -126.559 | -74.371 | 123.367 | 493.023 | 21.701 | 75.697 | 6.344 |
| EBITDA Ratio
| 0.447 | 0.018 | -5.468 | -1.193 | 0.438 | 0.691 | 0.154 | 0.717 | 0.153 |